GeoVax preclinical data show durable single-dose MVA protection
GeoVax says its next-generation MVA vaccine demonstrated durable single-dose protection in preclinical models, including protection against highly pathogenic Clade I mpox virus.
GeoVax says its next-generation MVA vaccine demonstrated durable single-dose protection in preclinical models, including protection against highly pathogenic Clade I mpox virus.